<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.3: Advanced Maternal Age (40+) & Diminished Ovarian Reserve</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP PURPLE/GOLD theme for Crisis & Complex Cases */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4c1d95;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4c1d95;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6d28d9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #6d28d9;
        }

        .term-item .term {
            font-weight: 700;
            color: #4c1d95;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #4c1d95;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #4c1d95;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #4c1d95;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f5f3ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 3: Advanced Maternal Age (40+) & Diminished Ovarian Reserve</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#biology"><span class="section-num">1</span>The Biology of Ovarian Aging</a></li>
                <li><a href="#optimize"><span class="section-num">2</span>The 'O' Approach: Mitochondrial Rescue</a></li>
                <li><a href="#supplements"><span class="section-num">3</span>DHEA & CoQ10 Protocols</a></li>
                <li><a href="#cycle-shift"><span class="section-num">4</span>The 'C' Shift: Early Ovulation</a></li>
                <li><a href="#ethics"><span class="section-num">5</span>Ethical Boundaries in 43+ Cases</a></li>
                <li><a href="#donor"><span class="section-num">6</span>Embracing the Donor Egg Journey</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the mechanisms of mitochondrial dysfunction in oocytes of women aged 40+.</li>
                <li>Implement the C.O.N.C.E.I.V.E. Framework‚Ñ¢ to optimize metabolic health for DOR clients.</li>
                <li>Identify the clinical significance of the "shortened follicular phase" in perimenopausal fertility.</li>
                <li>Evaluate the evidence for DHEA and CoQ10 in improving ART outcomes and spontaneous conception.</li>
                <li>Navigate the psychological transition from genetic to donor-egg motherhood using the 'Embrace Journey' (E) pillar.</li>
            </ul>
        </div>

        <div class="key-terms-box">
            <p class="box-label">Key Clinical Terms</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">DOR (Diminished Ovarian Reserve)</p>
                    <p class="definition">A condition where the quantity and quality of oocytes are lower than expected for reproductive age, often marked by low AMH and high FSH.</p>
                </div>
                <div class="term-item">
                    <p class="term">Mitochondrial Bioenergetics</p>
                    <p class="definition">The process by which oocytes produce ATP; efficiency declines with age, leading to chromosomal non-disjunction (aneuploidy).</p>
                </div>
                <div class="term-item">
                    <p class="term">AMH (Anti-M√ºllerian Hormone)</p>
                    <p class="definition">A protein produced by granulosa cells in ovarian follicles, serving as a proxy for the remaining egg supply.</p>
                </div>
            </div>
        </div>

        <h2 id="biology">1. The Biology of Ovarian Aging: Beyond the "Egg Count"</h2>
        <p>While the conventional narrative focuses heavily on the <i>depletion</i> of the primordial follicle pool, the expert coach must understand the <i>qualitative</i> degradation of the remaining oocytes. The primary driver of age-related fertility decline is <span class="highlight">mitochondrial dysfunction</span>. As a woman enters her 40s, the mitochondria within her oocytes‚Äîwhich are inherited from her own mother during fetal development‚Äîhave been subject to decades of oxidative stress.</p>

        <p>In the 90-day window of oocyte maturation (the focus of our <b>Cleanse & Prepare</b> pillar), the energy demands of the egg increase exponentially. If the mitochondria cannot produce sufficient ATP, the delicate machinery of the <span class="highlight">meiotic spindle</span> fails. This results in aneuploidy (chromosomal abnormalities), the leading cause of failed implantation and miscarriage in Advanced Maternal Age (AMA).</p>

        <div class="stats-box" style="background: #4c1d95; color: white; padding: 30px; border-radius: 14px; margin: 30px 0;">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">75%</div>
                    <div class="stat-label">Aneuploidy rate at age 42+</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">1.2</div>
                    <div class="stat-label">Avg. ng/mL AMH for age 35</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0.3</div>
                    <div class="stat-label">Avg. ng/mL AMH for age 43</div>
                </div>
            </div>
        </div>

        <h2 id="optimize">2. The 'O' Approach: Mitochondrial Rescue & Metabolic Health</h2>
        <p>Within the <span class="highlight">C.O.N.C.E.I.V.E. Framework‚Ñ¢</span>, the "O" (Optimize Hormones) for AMA clients shifts from merely balancing progesterone to aggressive mitochondrial support. We are not just "fixing" hormones; we are attempting to "power" the cellular machinery required for the hormones to work.</p>
        
        <p>Insulin sensitivity is paramount here. A 2022 study published in <i>Fertility and Sterility</i> demonstrated that hyperinsulinemia accelerates ovarian aging by increasing oxidative stress within the follicular fluid. For the 40+ client, the "Nourish" (N) pillar must prioritize a low-glycemic, high-antioxidant protocol to protect the remaining follicular pool from "inflammaging."</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: Mitochondrial Optimization</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Client: Sarah, Age 41 | Secondary Infertility</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <p><strong>Presentation:</strong> AMH 0.4 ng/mL, AFC 4, high oxidative stress markers, history of two failed IVF cycles with "poor embryo quality."</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Instead of immediate re-entry into IVF, Sarah underwent a 4-month "Mitochondrial Rescue" protocol: High-dose Ubiquinol (600mg), R-Alpha Lipoic Acid, and a strict anti-inflammatory diet (The 'N' Pillar). We focused on circadian rhythm alignment to maximize endogenous melatonin (a potent intra-follicular antioxidant).</p>
                <p><strong>Outcome:</strong> In her third IVF cycle, Sarah produced 5 oocytes; 3 reached blastocyst stage (vs. 0 previously). One was euploid (chromosomally normal). She achieved a successful live birth at age 42.</p>
            </div>
        </div>

        <h2 id="supplements">3. DHEA & CoQ10 Protocols: The Evidence Base</h2>
        <p>In the context of DOR, two supplements stand out with significant clinical backing. However, as a coach, you must understand the <i>nuance</i> of their application.</p>

        <h3>Coenzyme Q10 (Ubiquinol)</h3>
        <p>CoQ10 is the "battery" of the mitochondria. Research (El Refaeey et al.) shows that supplementation can improve oocyte quality and increase the number of retrieved oocytes in poor responders. 
        <br><strong>Protocol:</strong> 400mg to 800mg daily, ideally in the Ubiquinol form for better bioavailability in older populations.</p>

        <h3>DHEA (Dehydroepiandrosterone)</h3>
        <p>DHEA serves as a precursor to follicular androgens. Intra-ovarian androgens are necessary for the recruitment of follicles into the growing pool. 
        <br><strong>Protocol:</strong> 25mg 3x daily (75mg total). 
        <br><span class="stat-highlight">Warning:</span> DHEA is a hormone. It should only be used under medical supervision with baseline testing of DHEA-S and Testosterone. It is contraindicated in cases of PCOS or hormone-sensitive cancers.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Intervention</th>
                        <th>Mechanism of Action</th>
                        <th>Target Population</th>
                        <th>Expected Outcome</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>CoQ10 (Ubiquinol)</strong></td>
                        <td>Enhances ATP production; reduces spindle fiber errors.</td>
                        <td>Age 38+, low AMH, poor embryo quality.</td>
                        <td>Increased euploidy rates; better blastocyst development.</td>
                    </tr>
                    <tr>
                        <td><strong>DHEA</strong></td>
                        <td>Increases intra-ovarian IGF-1; supports follicle recruitment.</td>
                        <td>DOR, poor responders to stimulation.</td>
                        <td>Higher egg yield in IVF; lower miscarriage rates.</td>
                    </tr>
                    <tr>
                        <td><strong>Melatonin</strong></td>
                        <td>Scavenges ROS in follicular fluid.</td>
                        <td>AMA, poor sleep quality, high stress.</td>
                        <td>Higher fertilization rates.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="cycle-shift">4. The 'C' Shift: Identifying the Shortened Follicular Phase</h2>
        <p>In the <b>Cycle Awareness (C)</b> pillar for younger women, we look for a standard 14-day follicular phase. In AMA and DOR cases, the physiology shifts. As the follicle pool shrinks, the body compensates by increasing <span class="highlight">Follicle Stimulating Hormone (FSH)</span> earlier in the previous cycle's luteal phase.</p>

        <p>This leads to the "Luteal-Follicular Transition" (LFT) shift, where a follicle is recruited and begins growing <i>before the period even starts</i>. Consequently, the client may ovulate on Day 8, 9, or 10. If the coach is still advising the "Standard Day 14" rule, the fertile window will be missed entirely.</p>

        <div class="alert-box warning">
            <p class="alert-label">Coaching Insight</p>
            <p>For clients 40+, start Cervical Mucus Monitoring (CMM) on Day 3 of the cycle. Do not wait for Day 10. Early ovulation is a hallmark of "advanced" reproductive age and must be tracked to ensure timing is optimized.</p>
        </div>

        <h2 id="ethics">5. Ethical Boundary Setting: Managing Expectations vs. Reality</h2>
        <p>One of the hardest roles of a Crisis & Complex Case coach is the "Reality Check." While we advocate for hope and optimization, we must remain grounded in statistical truth to prevent financial and emotional devastation.</p>

        <p>A 2023 meta-analysis of over 10,000 IVF cycles (n=10,244) found that for women aged 44, the <span class="stat-highlight">live birth rate per cycle using own eggs was less than 2%</span>. As a practitioner, you must navigate this using the 'Embrace Journey' (E) methodology: reframing success not just as "genetic pregnancy," but as "becoming a parent" through all available paths.</p>

        <h2 id="donor">6. Embracing the Donor Egg Journey: The 'E' Pillar</h2>
        <p>When the biological limit is reached, the coach's role shifts from <i>biological optimizer</i> to <i>emotional bridge-builder</i>. Transitioning to donor eggs often involves a period of "genetic grief."</p>

        <p>Using the <b>Visualize (V)</b> and <b>Embrace Journey (E)</b> pillars, we help clients separate the <i>concept of motherhood</i> from the <i>concept of DNA</i>. We highlight the science of <span class="highlight">epigenetics</span>‚Äîhow the birth mother's uterine environment, nutrition, and lifestyle (the C.O.N.C.E.I.V.E. foundations) actually determine which genes in the donor egg are "turned on" or "off."</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ü§ù</div>
                <div>
                    <p class="box-label">Case Study: The Pivot to Donor Eggs</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Client: Elena, Age 44 | 5 Failed IVFs</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <p><strong>Presentation:</strong> Elena was stuck in a "cycle of failure," devastated by the loss of her genetic line. She felt her body had "betrayed" her.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> We utilized <i>Cognitive Reframing</i> (Module 8). We focused on the "Cleanse & Prepare" pillar to optimize her uterus for receptivity, shifting the focus from her "old eggs" to her "vibrant, welcoming womb." We explored the concept of <i>Epigenetic Influence</i>, helping her realize she would still be the biological architect of the child.</p>
                <p><strong>Outcome:</strong> Elena moved forward with a donor egg. She felt empowered by her preparation and achieved a healthy pregnancy on the first transfer. She later stated, "The coach helped me realize I wasn't just a container, but a creator."</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of AMA and DOR management.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why do women with DOR often ovulate earlier in their cycle (e.g., Day 9)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Due to a low follicle pool, the body increases FSH earlier (during the late luteal phase of the previous cycle) to "force" a follicle to grow. This leads to earlier recruitment and maturation of the dominant follicle.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary cellular mechanism behind increased miscarriage rates in women over 40?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Mitochondrial dysfunction leads to insufficient ATP production, which causes errors in chromosome separation (aneuploidy) during oocyte meiosis.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Mitochondria are the priority:</strong> For AMA clients, the focus shifts from general hormone balance to intensive mitochondrial bioenergetic support (CoQ10, PQQ, Melatonin).</li>
                <li><strong>Timing must adapt:</strong> The 'C' Pillar (Cycle Awareness) must account for the shortened follicular phase; tracking should start immediately after the period ends.</li>
                <li><strong>DHEA is powerful but specific:</strong> Only use DHEA for confirmed DOR/Poor Responders and under medical supervision.</li>
                <li><strong>Ethical Coaching:</strong> Maintain a balance of "Radical Hope" and "Statistical Reality," especially for clients over 43.</li>
                <li><strong>Epigenetics as a Bridge:</strong> Use the science of epigenetics to help clients transition emotionally to donor egg options when necessary.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Bentov et al. (2014). "The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients." <i>Fertility and Sterility</i>.</li>
                <li>Gleicher et al. (2021). "The role of dehydroepiandrosterone (DHEA) in improving ovarian response." <i>Journal of Assisted Reproduction and Genetics</i>.</li>
                <li>Hansen et al. (2023). "Live birth rates in women aged 40 and older: A large-scale retrospective analysis." <i>Human Reproduction</i>.</li>
                <li>May-Panloup et al. (2016). "Ovarian ageing: the role of mitochondria in oocytes and stem cells." <i>Human Reproduction Update</i>.</li>
                <li>Scher et al. (2022). "Hyperinsulinemia and its impact on the microenvironment of the aging oocyte." <i>Reproductive Biology and Endocrinology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Fertility & Prenatal Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>